A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Snyder Cappione, Jennifer E ^a   Tincati, Camilla ^a   Eccles James, Ijeoma G ^a   Cappione III, Amedeo J ^b   Ndhlovu, Lishomwa C ^a   Koth, Laura L ^a   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMD Millipore   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGENIC AGENT; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; CCL3 PROTEIN, HUMAN; CCL4 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL POPULATION; CELL SELECTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEIN SYNTHESIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; TH1 CELL; TH17 CELL; TH2 CELL; CELL CULTURE; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM;

ADULT; CELLS, CULTURED; CHEMOKINE CCL3; CHEMOKINE CCL4; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; NATURAL KILLER T-CELLS; SEX FACTORS; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 78149485537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015412     Document Type: Article

References (41)

1. Tyznik AJ, Tupin E, Nagarajan NA, Her MJ, Benedict CA, et al. (2008) Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J Immunol 181: 4452-4456.
2. de Lalla C, Galli G, Aldrighetti L, Romeo R, Mariani M, et al. (2004) Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 173: 1417-1425.
3. Gumperz JE, Miyake S, Yamamura T, Brenner MB (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195: 625-636.
4. Kim CH, Johnston B, Butcher EC (2002) Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100: 11-16.
5. Spada FM, Koezuka Y, Porcelli SA (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 188: 1529-1534.
6. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, et al. (1998) Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391: 177-181.
7. Exley M, Porcelli S, Furman M, Garcia J, Balk S (1998) CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains. J Exp Med 188: 867-876.
8. Lee PT, Benlagha K, Teyton L, Bendelac A (2002) Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med 195: 637-641.
9. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, et al. (2002) Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 110: 793-800.
10. Eger KA, Sundrud MS, Motsinger AA, Tseng M, Van Kaer L, et al. (2006) Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions. PLoS One 1: e50.
11. Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, et al. (2008) Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med 205: 385-393.
12. Lee KA, Kang MH, Lee YS, Kim YJ, Kim DH, et al. (2008) A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity. Cell Immunol.
13. Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, et al. (2008) Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and RORct and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6-Independent Fashion. J Immunol 180: 5167-5171.
14. Michel ML, Mendes-da-Cruz D, Keller AC, Lochner M, Schneider E, et al. (2008) Critical role of ROR-ct in a new thymic pathway leading to IL-17- producing invariant NKT cell differentiation. Proc Natl Acad Sci U S A 105: 19845-19850.
15. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6: 169-175.
16. Uemura Y, Liu TY, Narita Y, Suzuki M, Nakatsuka R, et al. (2009) Cytokinedependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells. J Immunol 183: 201-208.
17. Motohashi S, Nakayama T (2008) Clinical applications of natural killer T cellbased immunotherapy for cancer. Cancer Sci 99: 638-645.
18. Chackerian A, Alt J, Perera V, Behar SM (2002) Activation of NKT cells protects mice from tuberculosis. Infect Immun 70: 6302-6309.
19. Ilyinskii PO, Wang R, Balk SP, Exley MA (2006) CD1d mediates T-celldependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo. J Virol 80: 7146-7158.
20. Joyee AG, Qiu H, Wang S, Fan Y, Bilenki L, et al. (2007) Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections. J Immunol 178: 1048-1058.
21. Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, et al. (2002) Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immunol 168: 6007-6011.
22. Molling JW, Moreno M, de Groot J, van der Vliet HJ, von Blomberg BM, et al. (2008) Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases. Immunol Lett 118: 36-43.
23. Park JM, Terabe M, van den Broeke LT, Donaldson DD, Berzofsky JA (2005) Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13. Int J Cancer 114: 80-87.
24. Singh AK, Yang JQ, Parekh VV, Wei J, Wang CR, et al. (2005) The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristaneinduced lupus in mice. Eur J Immunol 35: 1143-1154.
25. Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M, Hong S, Bruna- Romero O, et al. (2000) alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murinemalaria. Proc Natl Acad SciUS A 97: 8461-8466.
26. Hansen DS, Siomos MA, Buckingham L, Scalzo AA, Schofield L (2003) Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 18: 391-402.
27. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, et al. (1998) Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 188: 1831-1839.
28. Mattner J, Savage PB, Leung P, Oertelt SS, Wang V, et al. (2008) Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3: 304-315.
29. Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, et al. (2001) Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194: 1801-1811.
30. Stanley AC, Zhou Y, Amante FH, Randall LM, Haque A, et al. (2008) Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis. PLoS Pathog 4: e1000028.
31. Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, et al. (2000) NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4RSTAT6 pathway. Nat Immunol 1: 515-520.
32. Terabe M, Swann J, Ambrosino E, Sinha P, Takaku S, et al. (2005) A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med 202: 1627-1633.
33. Neudorf S, Jones M, Parker S, Papes R, Lattier D (1991) Phorbol esters downregulate transcription and translation of the CD4 gene. J Immunol 146: 2836-2840.
34. Wu L, Van Kaer L (2009) Natural killer T cells and autoimmune disease. Curr Mol Med 9: 4-14.
35. Berzofsky JA, Terabe M (2009) The contrasting roles of NKT cells in tumor immunity. Curr Mol Med 9: 667-672.
36. Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6: 366-372.
37. Mostertz W, Stevenson M, Acharya C, Chan I, Walters K, et al. (2010) Age- and sex-specific genomic profiles in non-small cell lung cancer. JAMA 303: 535-543.
38. Gourdy P, Araujo LM, Zhu R, Garmy-Susini B, Diem S, et al. (2005) Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells. Blood 105: 2415-2420.
39. Snyder-Cappione JE, Loo CP, Carvalho KI, Kuylenstierna C, Deeks SG, et al. (2009) Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression. AIDS 23: 1965-1970.
40. Diana J, Griseri T, Lagaye S, Beaudoin L, Autrusseau E, et al. (2009) NKT cellplasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity 30: 289-299.
41. Wiethe C, Debus A, Mohrs M, Steinkasserer A, Lutz M, et al. (2008) Dendritic cell differentiation state and their interaction with NKT cells determine Th1/ Th2 differentiation in the murine model of Leishmania major infection. J Immunol 180: 4371-4381.